Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (221-230 of 333) with videos related to

Pageof 34
Sort By:
Hepatology (Baltimore, Md.)|May 7, 2025
Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunctionLaurens A van Kleef, Jesse Pustjens, Jörn M Schattenberg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 6, 2022
Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohortOmar Hahad, Volker H Schmitt, Natalie Arnold, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise programYvonne Huber, Daniel Pfirrmann, Ines Gebhardt, et al.
Gastro Hep Advances|April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult PopulationLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Ophthalmic Epidemiology|March 4, 2025
Prevalence of Retinal Vascular Anomalies in the German Population: Results from the Gutenberg Health StudyAnna M Voigt, Karl Neubert, Stella Hoh, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseMarie Boyle, Dina Tiniakos, Jorn M Schattenberg, et al.
JHEP Reports : Innovation in Hepatology|September 23, 2020
The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD careWolf Peter Hofmann, Peter Buggisch, Lisa Schubert, et al.
Pharmacological Research|December 27, 2024
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testingKarina Benderski, Paul Schneider, Panayiotis Kordeves, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 19, 2025
Tinnitus is not associated with cardiovascular risk factors or mortality in the Gutenberg Health StudyOmar Hahad, Berit Hackenberg, Julia Döge, et al.
Nature Reviews. Gastroenterology & Hepatology|June 26, 2021
Defining comprehensive models of care for NAFLDJeffrey V Lazarus, Quentin M Anstee, Hannes Hagström, et al.
Pageof 34

Showing results (221-230 of 333) with videos related to

Sort By:
Pageof 34
Hepatology (Baltimore, Md.)|May 7, 2025
Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunctionLaurens A van Kleef, Jesse Pustjens, Jörn M Schattenberg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 6, 2022
Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohortOmar Hahad, Volker H Schmitt, Natalie Arnold, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise programYvonne Huber, Daniel Pfirrmann, Ines Gebhardt, et al.
Gastro Hep Advances|April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult PopulationLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Ophthalmic Epidemiology|March 4, 2025
Prevalence of Retinal Vascular Anomalies in the German Population: Results from the Gutenberg Health StudyAnna M Voigt, Karl Neubert, Stella Hoh, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseMarie Boyle, Dina Tiniakos, Jorn M Schattenberg, et al.
JHEP Reports : Innovation in Hepatology|September 23, 2020
The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD careWolf Peter Hofmann, Peter Buggisch, Lisa Schubert, et al.
Pharmacological Research|December 27, 2024
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testingKarina Benderski, Paul Schneider, Panayiotis Kordeves, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 19, 2025
Tinnitus is not associated with cardiovascular risk factors or mortality in the Gutenberg Health StudyOmar Hahad, Berit Hackenberg, Julia Döge, et al.
Nature Reviews. Gastroenterology & Hepatology|June 26, 2021
Defining comprehensive models of care for NAFLDJeffrey V Lazarus, Quentin M Anstee, Hannes Hagström, et al.
Pageof 34